Form 8-K - Current report:
SEC Accession No. 0001013762-24-001207
Filing Date
2024-07-25
Accepted
2024-07-25 17:22:01
Documents
14
Period of Report
2024-07-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea021006501-8k_enzobio.htm   iXBRL 8-K 22078
2 EXECUTIVE EMPLOYMENT AGREEMENT BETWEEN ENZO BIOCHEM, INC. AND PATRICIA ECKERT, E ea021006501ex10-1_enzobio.htm EX-10.1 79544
  Complete submission text file 0001013762-24-001207.txt   296418

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE enz-20240724.xsd EX-101.SCH 3030
4 XBRL LABEL FILE enz-20240724_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE enz-20240724_pre.xml EX-101.PRE 22370
16 EXTRACTED XBRL INSTANCE DOCUMENT ea021006501-8k_enzobio_htm.xml XML 3557
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 241142938
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)